July 10, 2018

How Israel’s Weed Tech Industry Is Taking On America’s Opioid Crisis

America is beginning to see cannabis as an alternative to prescription pills. Israel is years ahead – and its entrepreneurs want to curb a crisis of opioid addiction that is completely out of control.

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

28/04/2021

Studies show the low-dose, smokeless device is effective at treating chronic pain without psychoactive effects.

The Pharmacokinetics, Efficacy, Safety, and Ease of Use of the SyqeAir Metered-Dose Cannabis Inhaler for Chronic Neuropathic Pain: A Phase 1a Study

12/12/2024

Syqe®’s first study (2014) examined whether metered and low doses of Δ9-THC allow for dose-dependent pain reduction of chronic neuropathic pain without significant adverse events. Listen to the podcast.

J-Wire & AJN: SyqeAir Inhaler available free to Australian veterans

11/05/2025

SyqeAir Inhaler received the Australia’s TGA approval and included in DVA’s funding scheme — enabling eligible veterans to access the treatment at no cost.

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.

Day: July 10, 2018

How Israel’s Weed Tech Industry Is Taking On America’s Opioid Crisis

Related Posts

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

The Pharmacokinetics, Efficacy, Safety, and Ease of Use of the SyqeAir Metered-Dose Cannabis Inhaler for Chronic Neuropathic Pain: A Phase 1a Study

J-Wire & AJN: SyqeAir Inhaler available free to Australian veterans